Demographic characteristics of lung transplant recipients’ post-transplantation and prior to the inclusion on the transplant waiting list in the Czech Republic 2009-2012_
| Characteristics | Pre–WL (N=163) | Post-Tx (N=53) |
|---|---|---|
| Gender (% male) | 67% | 62% |
| Age (years) (mean ± SD) | ||
| CF group | 30.66 ± 10.90 | 28.68 ± 8.81 |
| Non-CF group | 56.28 ± 8.69 | 54.38 ± 8.88 |
| Medical Diagnosis (%) | ||
| COPD group | 69 (42.3%) | 26 (49.1%) |
| Non-COPD group | 94 (57.7 | 27 (50.9%) |
Urinary cotinine concentrations of lung transplant (Tx) patients post-Tx and prior to the inclusion on the waiting list in the Czech Republic 2009-2012_ 80% of all patients one year post-Tx were tested in the observed period_
| Urinary cotinine concentrations (ng/ml) | Pre–WL (N=163) | Post-Tx (N=53) |
|---|---|---|
| Negative | 89.0% (145/163) | 81.1% (43/53) |
| (< 50 ng/ml) | 95% CI 0.821 to 0.921 | 95% CI 0.685 to 0.893 |
| Borderline | 6.1% (10/163) | 3.8% (2/53) |
| (50 ≤ X < 500 ng/ml) | 95% CI 0.033 to 0.108 | 95% CI 0.007 to 0.116 |
| Positive | 4.9% (8/163) | 15.1% (8/53) |
| (≥ 500 ng/ml) | 95% CI 0.078 to 0.094 | 95% CI 0.025 to 0.269 |
The comparison of urinary cotinine levels among patients with COPD & Emphysema and patients with other diagnoses post-lung Tx and prior to inclusion on the Tx waiting list_
| Urinary cotinine levels | COPD-group (n= 94) | Non-COPD group (n= 122) | ||
|---|---|---|---|---|
| Pre-WL | ||||
| Negative | 81.2% | 94.7% | ||
| (< 350 ng/ml) | (56/69) | (89/94) | ||
| Positive and Borderline | 18.8% | 5.3% | ||
| (≥ 50 ng/ml) | (13/69) | (5/94) | ||
| Odds ratio | 4.13 | |||
| 95% Cl | 1.40 to 12.22 | |||
| P-value | 0.010 | |||
| Post-Tx | ||||
| Negative | 61.5% | 100% | ||
| (< 50 ng/ml) | (16/26) | (27/27) | ||
| Positive and Borderline | 38.5% | 0% | ||
| (≥ 50 ng/ml) | (16/26) | (27/27) | ||
| Odds ratio | 35.00 | |||
| 95% Cl | 1.92 to 637.37 | |||
| P-value | 0.016 |